Funding for this research was provided by:
This research was supported by NHMRC, Leukaemia Foundation, Anthony Rothe Memorial Trust, NSW Cancer Council, Cancer Institute NSW, Tenix Foundation and ISG Foundation.
Text and Data Mining valid from 2019-01-22
Received: 11 December 2017
Revised: 21 August 2018
Accepted: 11 December 2018
First Online: 22 January 2019
Compliance with ethical standards
: Gudkov A.V. is a consultant of Oncotartis, Inc. which has licensed the CCI-006 compound from Children’s Cancer Institute.